<DOC>
	<DOCNO>NCT02224235</DOCNO>
	<brief_summary>Phase one study prospective , randomize ( 2:1 ) , pilot study evaluate COBRA PzF vascular healing pattern thrombus formation Optical Coherence Tomography ( OCT ) 3 month stent implantation comparison Resolute Integrity drug elute stent ( DES ) . Patients COBRA PzF ( Group 1 ) receive dual anti platelet one week follow aspirin , patient implant ZES ( Group 2 ) , receive Dual anti-platelet therapy ( DAPT ) least 6 month follow aspirin . After completion Phase 1 , Phase 2 enroll 10 patient COBRA PzF ( Group 3 ) . Patients Group 3 receive aspirin alone OCT one month stent procedure evaluate COBRA PzF vascular healing pattern thrombus formation one month follow .</brief_summary>
	<brief_title>COBRA SHIELD OCT Study</brief_title>
	<detailed_description />
	<mesh_term>Angina , Stable</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<criteria>Patient &gt; = 18 year old . Eligible percutaneous coronary intervention ( PCI ) . Patient provide write informed consent . Patient willing comply followup evaluation . Acceptable candidate coronary artery bypass graft ( CABG ) surgery . Stable angina pectoris positive functional ischemia study . Male nonpregnant female patient Patient indicate elective stenting 2 stenotic lesion two separate native coronary artery . Reference vessel &gt; =2.5 mm &lt; = 4.0 mm diameter visual estimate . Target lesion &lt; =20 mm length visual estimate . Protected leave main lesion &gt; 50 % stenosis . Target lesion stenosis &gt; = 70 % &lt; 100 % visual estimate OR Target lesion stenosis &lt; 70 % meet physiological criterion revascularization ( i.e . positive Fractional Flow Reserve ) . Currently enrol another investigational device drug trial . Previously enrol another stent trial within prior 2 year . ANY plan elective surgery percutaneous intervention within subsequent 3 month . A previous coronary interventional procedure kind within 30 day prior procedure . The patient require staged procedure either target nontarget vessel OCT procedure 3 month postprocedure . The target lesion require treatment device percutaneous transluminal coronary angioplasty ( PTCA ) prior stent placement . Previous drug elute stent ( DES ) bare metal stent ( BMS ) deployment anywhere target vessel . Comorbid condition ( ) could limit patient 's ability participate trial comply followup requirement , impact scientific integrity trial . Concurrent medical condition life expectancy le 12 month . Documented leave ventricular ejection fraction ( LVEF ) &lt; 50 % recent evaluation . Patients diagnosis myocardial infarction ( MI ) within 72 hour ( i.e . CKMB must return normal prior enrollment ) suspect acute MI time enrollment . Previous intervention target vessel . History cerebrovascular accident transient ischemic attack last 6 month . Leukopenia ( leukocytes &lt; 3.5 x10^9 / liter ) . Neutropenia ( Absolute Neutrophil Count &lt; 1000/mm3 ) &lt; = 3 day prior enrollment . Thrombocytopenia ( platelet &lt; 100,000/mm3 ) preprocedure . Active peptic ulcer active GI bleeding . History bleed diathesis coagulopathy inability accept blood transfusion . Known hypersensitivity contraindication aspirin , heparin bivalirudin , clopidogrel ticlopidine , cobalt , nickel , L605 Cobalt chromium alloy sensitivity contrast medium , adequately premedicated . Serum creatinine level &gt; 2.0 mg/dl within 7 day prior index procedure . Patients responsive Plavix/ aspirin unable tolerate Plavix/ aspirin 6 month post procedure . Patient may require anticoagulation therapy within 3 month index procedure . Flow limit dissection observe OCT Significant tissue prolapse within stent observe OCT Unprotected leave main coronary artery disease Target vessel lesion great 60 % diameter stenosis outside range 5 mm proximal distal target lesion base visual estimate online quantitative coronary arteriography ( QCA ) . Target lesion ( vessel ) exhibit intraluminal thrombus ( occupy &gt; 50 % true lumen diameter ) time . Lesion location aortoostial within 5 mm origin leave anterior descending ( LAD ) leave circumflex ( LCX ) . Target lesion side branch &gt; 2.0mm diameter . Target vessel excessively tortuous ( two bend &gt; 90Ëš reach target lesion ) . Target lesion severely calcify . Thrombolysis In Myocardial Infarction ( TIMI ) flow 0 1 Target lesion bypass graft</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Stable angina</keyword>
	<keyword>PCI</keyword>
	<keyword>Percutaneous Coronary Intervention</keyword>
</DOC>